These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18383859)

  • 21. A novel butyrolactone derivative inhibited smooth muscle cell migration and proliferation and maintained endothelial cell functions through selectively affecting Na, K-ATPase activity and mitochondria membrane potential during in vitro angiogenesis.
    Meng N; Zhao J; Zhao B; Cheng Y; Wang W; Zhang Y; Zhang S; Miao J
    J Cell Biochem; 2008 Aug; 104(6):2123-30. PubMed ID: 18393353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic administration of a conditionally replicating adenovirus, targeted to angiogenesis, reduced lung metastases burden in cotton rats.
    Peled M; Shaish A; Katav A; Greenberger S; Barshack I; Tal R; Bangio L; Breitbart E; Harats D
    Clin Cancer Res; 2009 Mar; 15(5):1664-73. PubMed ID: 19240175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of plant extracts on angiogenic activities of endothelial cells and keratinocytes.
    Łoboda A; Cisowski J; Zarebski A; Jaźwa A; Riviera Nunez D; Kypriotakis Z; Heinrich M; Dulak J
    J Physiol Pharmacol; 2005 Mar; 56 Suppl 1():125-37. PubMed ID: 15800390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual functions of a monoclonal antibody against cell surface F1F0 ATP synthase on both HUVEC and tumor cells.
    Zhang X; Gao F; Yu LL; Peng Y; Liu HH; Liu JY; Yin M; Ni J
    Acta Pharmacol Sin; 2008 Aug; 29(8):942-50. PubMed ID: 18664327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets.
    Albini A; Dell'Eva R; Vené R; Ferrari N; Buhler DR; Noonan DM; Fassina G
    FASEB J; 2006 Mar; 20(3):527-9. PubMed ID: 16403733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.
    Guruvayoorappan C; Kuttan G
    Innate Immun; 2008 Jun; 14(3):160-74. PubMed ID: 18562575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro anti-angiogenic action of lambda-carrageenan oligosaccharides].
    Chen HM; Yan XJ; Wang F; Lin J; Xu WF
    Yao Xue Xue Bao; 2007 Jun; 42(6):595-600. PubMed ID: 17702394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro.
    Guidolin D; Vacca A; Nussdorfer GG; Ribatti D
    Microvasc Res; 2004 Mar; 67(2):117-24. PubMed ID: 15020202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic properties of silver nanoparticles.
    Gurunathan S; Lee KJ; Kalishwaralal K; Sheikpranbabu S; Vaidyanathan R; Eom SH
    Biomaterials; 2009 Oct; 30(31):6341-50. PubMed ID: 19698986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.
    Kallander LS; Lu Q; Chen W; Tomaszek T; Yang G; Tew D; Meek TD; Hofmann GA; Schulz-Pritchard CK; Smith WW; Janson CA; Ryan MD; Zhang GF; Johanson KO; Kirkpatrick RB; Ho TF; Fisher PW; Mattern MR; Johnson RK; Hansbury MJ; Winkler JD; Ward KW; Veber DF; Thompson SK
    J Med Chem; 2005 Sep; 48(18):5644-7. PubMed ID: 16134930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lupulone, a hop bitter acid, activates different death pathways involving apoptotic TRAIL-receptors, in human colon tumor cells and in their derived metastatic cells.
    Lamy V; Roussi S; Chaabi M; Gossé F; Lobstein A; Raul F
    Apoptosis; 2008 Oct; 13(10):1232-42. PubMed ID: 18726190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents.
    Zerp SF; Vink SR; Ruiter GA; Koolwijk P; Peters E; van der Luit AH; de Jong D; Budde M; Bartelink H; van Blitterswijk WJ; Verheij M
    Anticancer Drugs; 2008 Jan; 19(1):65-75. PubMed ID: 18043131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis.
    Singh SK; Bhusari S; Singh R; Saxena A; Mondhe D; Qazi GN
    Vascul Pharmacol; 2007 May; 46(5):333-7. PubMed ID: 17257903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
    Chintalapati M; Truax R; Stout R; Portier R; Losso JN
    J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of huangqi and dangshen extraction on angiogenesis in Matrigel implant of mice].
    Bai CQ; Song YF; Jian W; Wang DT; Ma CB
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):498-9. PubMed ID: 18466712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis.
    Zania P; Gourni D; Aplin AC; Nicosia RF; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
    J Pharmacol Exp Ther; 2009 Feb; 328(2):378-89. PubMed ID: 18988770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of mathematical morphology to the quantification of in vitro endothelial cell organization into tubular-like structures.
    Angulo J; Matou S
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(2):22-35. PubMed ID: 17531137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of potent and practical antiangiogenic agents inspired by cortistatin A.
    Czakó B; Kürti L; Mammoto A; Ingber DE; Corey EJ
    J Am Chem Soc; 2009 Jul; 131(25):9014-9. PubMed ID: 19469509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.
    Sun HL; Tsai AC; Pan SL; Ding Q; Yamaguchi H; Lin CN; Hung MC; Teng CM
    Clin Cancer Res; 2009 Aug; 15(15):4904-14. PubMed ID: 19622586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.